Andretta, E.; Longo, R.; Balladelli, M.; Sgarabotto, C.; Sgarabotto, D.
Intravesical Gentamicin: An Option for Therapy and Prophylaxis against Recurrent UTIs and Resistant Bacteria in Neurogenic Bladder Patients on Intermittent Catheterization. Antibiotics 2022, 11, 1335.
https://doi.org/10.3390/antibiotics11101335
AMA Style
Andretta E, Longo R, Balladelli M, Sgarabotto C, Sgarabotto D.
Intravesical Gentamicin: An Option for Therapy and Prophylaxis against Recurrent UTIs and Resistant Bacteria in Neurogenic Bladder Patients on Intermittent Catheterization. Antibiotics. 2022; 11(10):1335.
https://doi.org/10.3390/antibiotics11101335
Chicago/Turabian Style
Andretta, Elena, Raffaele Longo, Massimo Balladelli, Camilla Sgarabotto, and Dino Sgarabotto.
2022. "Intravesical Gentamicin: An Option for Therapy and Prophylaxis against Recurrent UTIs and Resistant Bacteria in Neurogenic Bladder Patients on Intermittent Catheterization" Antibiotics 11, no. 10: 1335.
https://doi.org/10.3390/antibiotics11101335
APA Style
Andretta, E., Longo, R., Balladelli, M., Sgarabotto, C., & Sgarabotto, D.
(2022). Intravesical Gentamicin: An Option for Therapy and Prophylaxis against Recurrent UTIs and Resistant Bacteria in Neurogenic Bladder Patients on Intermittent Catheterization. Antibiotics, 11(10), 1335.
https://doi.org/10.3390/antibiotics11101335
